Zoledronic Acid Effectively Decreases Pain Associated With Bone Metastases
by Zangani • 10 November 2011 • Pain News
A brief course of the bisphosphonate zoledronic acid (Zometa, Novartis) significantly decreased the pain associated with bone metastases, according to a study presented at the European Multidisciplinary Cancer Congress, held recently in Berlin (abstract 3062).